Compass Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CMPX and other ETFs, options, and stocks.About CMPX
Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. Its platform includes common light chain-focused antibody discovery, human display for antibody tuning, stitchmabs, and highly modular and manufacturable bispecific candidates.
CEOThomas J. Schuetz
CEOThomas J. Schuetz
Employees35
Employees35
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2014
Founded2014
Employees35
Employees35
CMPX Key Statistics
Market cap982.69M
Market cap982.69M
Price-Earnings ratio-12.08
Price-Earnings ratio-12.08
Dividend yield—
Dividend yield—
Average volume2.21M
Average volume2.21M
High today$5.74
High today$5.74
Low today$5.48
Low today$5.48
Open price$5.59
Open price$5.59
Volume1.14M
Volume1.14M
52 Week high$5.86
52 Week high$5.86
52 Week low$1.33
52 Week low$1.33
Stock Snapshot
With a market cap of 982.69M, Compass Therapeutics(CMPX) trades at $5.52. The stock has a price-to-earnings ratio of -12.08.
As of 2025-12-08, Compass Therapeutics(CMPX) stock has fluctuated between $5.48 and $5.74. The current price stands at $5.52, placing the stock +0.7% above today's low and -3.8% off the high.
Compass Therapeutics(CMPX) shares are trading with a volume of 1.14M, against a daily average of 2.21M.
During the past year, Compass Therapeutics(CMPX) stock moved between $1.33 at its lowest and $5.86 at its peak.
During the past year, Compass Therapeutics(CMPX) stock moved between $1.33 at its lowest and $5.86 at its peak.
Analyst ratings
100%
of 14 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CMPX. This list is generated using Robinhood data, and it’s not a recommendation.